Order Article Reprints

Wander P, Arentsen-Peters STCJM, Vrenken KS, Pinhanҫos SM, Koopmans B, Dolman MEM, Jones L, Garrido Castro P, Schneider P, Kerstjens M, et al. High-Throughput Drug Library Screening in Primary KMT2A-Rearranged Infant ALL Cells Favors the Identification of Drug Candidates That Activate P53 Signaling. Biomedicines. 2022; 10(3):638. https://doi.org/10.3390/biomedicines10030638

Wander, Priscilla, Susan T. C. J. M. Arentsen-Peters, Kirsten S. Vrenken, Sandra Mimoso Pinhanҫos, Bianca Koopmans, M. Emmy M. Dolman, Luke Jones, Patricia Garrido Castro, Pauline Schneider, Mark Kerstjens, and et al. 2022. "High-Throughput Drug Library Screening in Primary KMT2A-Rearranged Infant ALL Cells Favors the Identification of Drug Candidates That Activate P53 Signaling" Biomedicines 10, no. 3: 638. https://doi.org/10.3390/biomedicines10030638

Wander, P., Arentsen-Peters, S. T. C. J. M., Vrenken, K. S., Pinhanҫos, S. M., Koopmans, B., Dolman, M. E. M., Jones, L., Garrido Castro, P., Schneider, P., Kerstjens, M., Molenaar, J. J., Pieters, R., Zwaan, C. M., & Stam, R. W. (2022). High-Throughput Drug Library Screening in Primary KMT2A-Rearranged Infant ALL Cells Favors the Identification of Drug Candidates That Activate P53 Signaling. Biomedicines, 10(3), 638. https://doi.org/10.3390/biomedicines10030638